Finance

Lists
Why is 301230 down 2,28%?
Dive Deeper
301230:SHE
PharmaResources (Shanghai) Co Ltd
CNÂ¥32,16
-2,28%
(-0,75) 1D
15 Okt., 13:23:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301230...
Open
CNÂ¥32,21
High
CNÂ¥34,07
Low
CNÂ¥32,14
Mkt. cap
6,20 mjd
Avg. vol.
16,40 m
Volume
10,76 m
Dividend
0,89%
Quarterly dividend
CNÂ¥0,07
Ex-dividend date
16 Jul. 2026
P/E ratio
153,54
52-wk high
CNÂ¥52,28
52-wk low
CNÂ¥22,23
EPS
CNÂ¥0,21
Shares outstanding
180,94 m
No. of employees
1 k
Open
CNÂ¥32,21
High
CNÂ¥34,07
Low
CNÂ¥32,14
Mkt. cap
6,20 mjd
Avg. vol.
16,40 m
Volume
10,76 m
Dividend
0,89%
Quarterly dividend
CNÂ¥0,07
Ex-dividend date
16 Jul. 2026
P/E ratio
153,54
52-wk high
CNÂ¥52,28
52-wk low
CNÂ¥22,23
EPS
CNÂ¥0,21
Shares outstanding
180,94 m
No. of employees
1 k
News stories
From web sources and news partners
About PharmaResources (Shanghai) Co Ltd
CEO-
Employees1,3 k
Founded14 Des. 2007
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
161,66 m
173,95 m
172,29 m
192,12 m
Cost of goods sold
113,37 m
141,40 m
117,29 m
154,67 m
Cost of revenue
113,37 m
141,40 m
117,29 m
154,67 m
Research and development expenses
9,80 m
8,36 m
10,74 m
10,16 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,90 m
31,02 m
27,59 m
28,57 m
Operating expense
37,54 m
41,00 m
38,16 m
41,06 m
Total operating expenses
150,91 m
182,40 m
155,45 m
195,73 m
Operating income
10,75 m
-8,45 m
16,83 m
-3,61 m
Other non operating income
1,57 m
-1,69 m
-2,12 m
2,05 m
EBT including unusual items
9,15 m
-3,51 m
25,98 m
4,15 m
EBT excluding unusual items
8,67 m
-11,07 m
19,90 m
-2,44 m
Income tax expense
-840,10 k
-3,05 m
2,21 m
-800,39 k
Effective tax rate
-9,18%
87,04%
8,49%
-19,29%
Other operating expenses
896,06 k
306,17 k
327,40 k
312,57 k
Net income
9,99 m
-454,81 k
23,78 m
4,95 m
Net profit margin
6,18%
-0,26%
13,80%
2,58%
Earnings per share
-
-
-
-
Interest and investment income
288,09 k
177,60 k
7,10 m
5,13 m
Interest expense
-2,04 m
-1,98 m
-1,91 m
-1,77 m
Net interest expenses
-1,75 m
-1,80 m
5,18 m
3,35 m
Depreciation and amortization charges
-
-
-
-
EBITDA
17,23 m
-1,39 m
23,90 m
3,89 m
Gain or loss from assets sale
-
-41,52 k
-
-
AI content may include mistakes. Learn more
Google-programme